ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion)

ClinicalTrials.gov ID: NCT05850520

Public ClinicalTrials.gov record NCT05850520. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 3:47 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Masked, Active-Controlled, Phase 3 Study of the Efficacy and Safety of Aflibercept 8 mg in Macular Edema Secondary to Retinal Vein Occlusion

Study identification

NCT ID
NCT05850520
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
892 participants

Conditions and interventions

Interventions

  • Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_2 mg Drug
  • Aflibercept, VEGF Trap-Eye(Eylea, BAY86-5321)_higher dose Drug
  • Fluorescein Diagnostic Test
  • Sham Drug

Drug · Diagnostic Test

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 14, 2023
Primary completion
Nov 6, 2024
Completion
May 26, 2025
Last update posted
Dec 17, 2025

2023 – 2025

United States locations

U.S. sites
53
U.S. states
24
U.S. cities
51
Facility City State ZIP Site status
Retina Consultants of Orange County - Fullerton Fullerton California 92835
South Coast Retina - Long Beach Long Beach California 90807
Northern California Retina Vitreous Associates - Mountain View Office Mountain View California 94040
Desert Retina Consultants - Palm Springs Office Palm Springs California 92262
Azul Vision Pasadena Pasadena California 91107
Retina Consultants of Southern California Redlands California 92374
Retina Consultants of Southern Colorado, PC Colorado Springs Colorado 80909
New England Retina Associates New London Connecticut 06320
Rand Eye Institute Deerfield Beach Florida 33064
National Ophthalmic Research Institute - Fort Myers Fort Myers Florida 33912
The Eye Institute of West Florida - Largo Largo Florida 33770
Florida Eye Associates - Melbourne Main Office Melbourne Florida 32901
Florida Retina Institute - Orlando Orlando Florida 32806
Retina Specialty Institute - Pensacola Pensacola Florida 32503
Fort Lauderdale Eye Institute Plantation Florida 33324
Retina Vitreous Associates of Florida - Saint Petersburg St. Petersburg Florida 33711
East Florida Eye Institute Stuart Florida 34994
Center for Retina and Macular Disease - Winter Haven Winter Haven Florida 33880
Marietta Eye Clinic Marietta Georgia 30060
Retina Associates - Elmhurst Elmhurst Illinois 60126
University Retina and Macula Associates - Oak Forest Oak Forest Illinois 60452
Retina Associates - Lenexa Lenexa Kansas 66215
The Retina Care Center - Baltimore Baltimore Maryland 21209
Cumberland Valley Retina Consultants | Hagerstown, MD Hagerstown Maryland 21740
Mid Atlantic Retina Specialists - Hagerstown Hagerstown Maryland 21740
Vitreo-Retinal Associates - Worcester Grand Rapids Michigan 49525
RCM - St. Louis Park Retina Clinic Saint Louis Park Minnesota 55416
Retina Consultants of Nevada - Summerlin Las Vegas Nevada 89144
Retina Center of New Jersey Bloomfield New Jersey 07003
NJ Retina - New Brunswick New Brunswick New Jersey 08901
NJ Retina | Teaneck Teaneck New Jersey 07666
Vision Research Center Albuquerque New Mexico 87109
Vitreoretinal Consultants of NY - Great Neck Great Neck New York 11021
Vitreoretinal Consultants of NY - Hauppauge Hauppauge New York 11788
Ophthalmic Consultants of Long Island Lynbrook New York 11563
Retina Associates of Western New York Rochester New York 14620
Cincinnati Eye Institute - Blue Ash Blue Ash Ohio 45242-5664
Midwest Retina - Main Office Dublin Ohio 43016
Retina Consultants, LLC Salem Oregon 97302
Mid Atlantic Retina - Bethlehem Bethlehem Pennsylvania 18107
Mid Atlantic Retina - Philadelphia / Wills Eye Hospital Philadelphia Pennsylvania 19107
Palmetto Retina Center, LLC - Florence Florence South Carolina 29501
Retina Consultants of South Carolina - Ladson Ladson South Carolina 29456
Charles Retina Specialists - Germantown Memphis Tennessee 38119
Austin Retina Associates - Central Austin Texas 78705
Retina Consultants of Texas - Bellaire Bellaire Texas 77401
Texas Retina Associates - Fort Worth Fort Worth Texas 76104
Medical Center Ophthalmology Associates - Northwest San Antonio Texas 78240
Retina Consultants of Texas - San Antonio Medical Center San Antonio Texas 78240
Rocky Mountain Retina Consultants - Main Office Salt Lake City Utah 84107
The Retina Group of Washington - Fairfax Fairfax Virginia 22031
Spokane Eye Clinical Research - South Hill / Downtown Spokane Washington 99204
UW Health Carbone Cancer Center Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 220 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05850520, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 17, 2025 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05850520 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →